GE HealthCare initiated with a Buy at Stifel

Stifel initiated coverage of GE HealthCare with a Buy rating and $100 price target. The company operates as a critical diagnostic and patient care technology provider, with global market-leading positions in imaging and ultrasound, the analyst tells investors in a research note. The firm says GE HealthCare “represents a classic MedTech spinoff story” poised to benefit from improved management and commercial execution, stronger cost reduction focus, optimized innovation-related investments, and growth-enhancing acquisitions. It believes the company is set favorably for continued mid-single-digit growth, meaningful operating margin expansion, and strong free cash flow generation.